Charles River Laboratories (CRL)

Depreciation & Amortization

$297.88M

TTM · Period ending: · USD

CRL logo

CRL Depreciation & Amortization

Latest reported$297.88M
CRL TTM Depreciation & Amortization ($18.87M → $297.88M)
High-resolution chart · PNG

CRL depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Charles River Laboratories Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
297,882,000
350,099,000
403,312,000
427,139,000
430,173,000
396,748,000
361,741,000
340,151,000
330,823,000
322,412,000
314,124,000
311,155,000
306,890,000
305,640,000
303,870,000
293,566,000
287,647,000
279,331,000
265,540,000
259,175,000
250,069,000
239,172,000
234,924,000
225,881,000
218,059,000
209,997,000
198,095,000
187,843,000
179,677,000
173,927,000
161,779,000
153,682,000
143,555,000
131,958,000
131,159,000
133,217,000
133,860,000
134,414,000
126,658,000
116,667,000
106,373,000
97,168,000
94,881,000
95,340,000
97,609,000
98,763,000
96,445,000
99,735,000
100,568,000
96,676,000
96,636,000
87,994,000
81,628,000
81,283,000
81,275,000
81,598,000
82,216,000
83,967,000
85,230,000
85,899,000
88,216,000
89,325,000
91,640,000
93,835,000
95,188,000
95,163,000
93,553,000
92,601,000
90,737,000
90,872,000
91,249,000
92,204,000
91,817,000
90,649,000
88,916,000
87,603,000
86,495,000
85,714,000
85,130,000
89,541,000
100,681,000
98,596,000
104,637,000
101,065,000
76,929,000
66,067,000
48,176,000
33,641,000
32,808,000
32,121,000
31,121,000
29,183,000
28,372,000
27,099,000
25,727,000
27,087,000
27,728,000
28,494,000
28,578,000
25,130,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.